Becton Dickinson Long Term Debt 2010-2024 | BDX
Becton Dickinson long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
- Becton Dickinson long term debt for the quarter ending September 30, 2024 was $17.940B, a 21.73% increase year-over-year.
- Becton Dickinson long term debt for 2024 was $17.94B, a 21.73% increase from 2023.
- Becton Dickinson long term debt for 2023 was $14.738B, a 6.14% increase from 2022.
- Becton Dickinson long term debt for 2022 was $13.886B, a 18.84% decline from 2021.
Becton Dickinson Annual Long Term Debt
(Millions of US $) |
| 2024 |
$17,940 |
| 2023 |
$14,738 |
| 2022 |
$13,886 |
| 2021 |
$17,110 |
| 2020 |
$17,224 |
| 2019 |
$18,081 |
| 2018 |
$18,894 |
| 2017 |
$18,667 |
| 2016 |
$10,550 |
| 2015 |
$11,370 |
| 2014 |
$3,768 |
| 2013 |
$3,763 |
| 2012 |
$3,761 |
| 2011 |
$2,485 |
| 2010 |
$1,495 |
| 2009 |
$1,488 |
Becton Dickinson Quarterly Long Term Debt
(Millions of US $) |
| 2024-09-30 |
$17,940 |
| 2024-06-30 |
$18,131 |
| 2024-03-31 |
$15,995 |
| 2023-12-31 |
$14,094 |
| 2023-09-30 |
$14,738 |
| 2023-06-30 |
$14,926 |
| 2023-03-31 |
$16,010 |
| 2022-12-31 |
$14,268 |
| 2022-09-30 |
$13,886 |
| 2022-06-30 |
$14,683 |
| 2022-03-31 |
$17,584 |
| 2021-12-31 |
$16,360 |
| 2021-09-30 |
$17,110 |
| 2021-06-30 |
$15,700 |
| 2021-03-31 |
$17,718 |
| 2020-12-31 |
$16,082 |
| 2020-09-30 |
$17,224 |
| 2020-06-30 |
$17,090 |
| 2020-03-31 |
$16,809 |
| 2019-12-31 |
$16,949 |
| 2019-09-30 |
$18,081 |
| 2019-06-30 |
$18,016 |
| 2019-03-31 |
$17,556 |
| 2018-12-31 |
$17,817 |
| 2018-09-30 |
$18,894 |
| 2018-06-30 |
$20,350 |
| 2018-03-31 |
$22,589 |
| 2017-12-31 |
$22,095 |
| 2017-09-30 |
$18,667 |
| 2017-06-30 |
$18,563 |
| 2017-03-31 |
$9,082 |
| 2016-12-31 |
$9,043 |
| 2016-09-30 |
$10,550 |
| 2016-06-30 |
$10,561 |
| 2016-03-31 |
$10,864 |
| 2015-12-31 |
$10,858 |
| 2015-09-30 |
$11,370 |
| 2015-06-30 |
$11,367 |
| 2015-03-31 |
$12,128 |
| 2014-12-31 |
$9,940 |
| 2014-09-30 |
$3,768 |
| 2014-06-30 |
$3,768 |
| 2014-03-31 |
$3,764 |
| 2013-12-31 |
$3,764 |
| 2013-09-30 |
$3,763 |
| 2013-06-30 |
$3,763 |
| 2013-03-31 |
$3,762 |
| 2012-12-31 |
$3,762 |
| 2012-09-30 |
$3,761 |
| 2012-06-30 |
$3,761 |
| 2012-03-31 |
$3,964 |
| 2011-12-31 |
$3,972 |
| 2011-09-30 |
$2,485 |
| 2011-06-30 |
$2,485 |
| 2011-03-31 |
$2,484 |
| 2010-12-31 |
$2,485 |
| 2010-09-30 |
$1,495 |
| 2010-06-30 |
$1,493 |
| 2010-03-31 |
$1,490 |
| 2009-12-31 |
$1,488 |
| 2009-09-30 |
$1,488 |
| 2009-06-30 |
$1,484 |
| 2009-03-31 |
$748 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$64.714B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
